Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Bacterial NDH-1 is a key gut target of metformin mediating its antidiabetic effects. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1038/nature25979
10.1038/nature25979 · External reference
10.1101/2025.03.23.644574
10.1101/2025.03.23.644574 · External reference
Non-antibiotic pharmaceuticals promote the transmission of multidrug resistance plasmids through intra- and intergenera conjugation
10.1038/s41396-021-00945-7 · 2021 · External reference
Non-antibiotic pharmaceuticals enhance the transmission of exogenous antibiotic resistance genes through bacterial transformation
10.1038/s41396-020-0679-2 · 2020 · External reference
Fate of environmental pollutants: A review
10.1002/wer.1404 · 2020 · External reference
10.1073/pnas.2113947119
10.1073/pnas.2113947119 · External reference
10.1002/etc.5684
10.1002/etc.5684 · External reference
10.1016/j.envpol.2018.08.075
10.1016/j.envpol.2018.08.075 · External reference
10.1007/s00125-017-4318-z
10.1007/s00125-017-4318-z · External reference
10.1002/pdi.606
10.1002/pdi.606 · External reference
10.1016/j.metabol.2022.155223
10.1016/j.metabol.2022.155223 · External reference
Unresolved reference
External reference
10.1016/j.diabres.2019.107946
10.1016/j.diabres.2019.107946 · External reference
10.3390/ph13120427
10.3390/ph13120427 · External reference
Recommendations for Practical Use of Metformin, a Central Pharmacological Therapy in Type 2 Diabetes
10.2337/cd21-0043 · 2022 · External reference
Metformin: Diverse molecular mechanisms, gastrointestinal effects and overcoming intolerance in type 2 Diabetes Mellitus: A review
10.1097/md.0000000000040221 · 2024 · External reference
Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes
10.1016/j.cmet.2020.04.021 · 2020 · External reference
10.1007/s00125-019-4848-7
10.1007/s00125-019-4848-7 · External reference
The Relationship between the Gut Microbiome and Metformin as a Key for Treating Type 2 Diabetes Mellitus
10.3390/ijms22073566 · 2021 · External reference
10.3390/ph18010055
10.3390/ph18010055 · External reference
10.1016/j.pharmr.2025.100106
10.1016/j.pharmr.2025.100106 · External reference
10.1126/sciadv.ads5466
10.1126/sciadv.ads5466 · External reference
10.3390/biology13050302
10.3390/biology13050302 · External reference
10.1136/bmjdrc-2022-003149
10.1136/bmjdrc-2022-003149 · External reference
Metformin Alters Upper Small Intestinal Microbiota that Impact a Glucose-SGLT1-Sensing Glucoregulatory Pathway
10.1016/j.cmet.2017.09.019 · 2018 · External reference
10.1038/msb4100050
10.1038/msb4100050 · External reference
10.1128/aac.00497-10
10.1128/aac.00497-10 · External reference
10.3390/ph15040453
10.3390/ph15040453 · External reference
Quinone chemistry in respiratory complex I involves protonation of a conserved aspartic acid residue
10.1002/1873-3468.15013 · 2024 · External reference
10.3389/fbioe.2022.1086261
10.3389/fbioe.2022.1086261 · External reference
10.1038/s41467-024-50409-7
10.1038/s41467-024-50409-7 · External reference
Global lessons from antibiotic resistance: Metformin-hydrolysing genes in transposable elements, a new threat for type II diabetic patients?
10.1016/j.jgar.2026.08.026 · 2026 · External reference
Metformin as a Potential Adjuvant Antimicrobial Agent Against Multidrug Resistant Bacteria
10.2147/cpaa.s297903 · 2021 · External reference
10.1186/s12866-023-02969-9
10.1186/s12866-023-02969-9 · External reference
10.1016/j.isci.2024.108900
10.1016/j.isci.2024.108900 · External reference
10.1007/s00125-015-3844-9
10.1007/s00125-015-3844-9 · External reference
Metformin Biodistribution: A Key to Mechanisms of Action?
10.1210/clinem/dgaa332 · 2020 · External reference
10.1016/j.jbc.2023.105363
10.1016/j.jbc.2023.105363 · External reference
10.1093/nar/28.1.27
10.1093/nar/28.1.27 · External reference
The return of metabolism: biochemistry and physiology of glycolysis
10.1111/brv.70104 · 2026 · External reference
10.2337/db11-0961
10.2337/db11-0961 · External reference
10.1007/s12020-019-02116-3
10.1007/s12020-019-02116-3 · External reference
10.1371/journal.pone.0074355
10.1371/journal.pone.0074355 · External reference
10.3389/fendo.2018.00753
10.3389/fendo.2018.00753 · External reference
Mitochondrial Complex I Inhibition by Metformin: Drug–Exercise Interactions
10.1016/j.tem.2020.02.003 · 2020 · External reference
10.1186/s12967-015-0443-y
10.1186/s12967-015-0443-y · External reference
The NAMPT Inhibitor FK866 Increases Metformin Sensitivity in Pancreatic Cancer Cells
10.3390/cancers14225597 · 2022 · External reference
Environment Dictates Dependence on Mitochondrial Complex I for NAD+ and Aspartate Production and Determines Cancer Cell Sensitivity to Metformin
10.1016/j.cmet.2016.09.006 · 2016 · External reference
10.1128/jb.184.14.3909-3916.2002
10.1128/jb.184.14.3909-3916.2002 · External reference
Reliable Metabolic Flux Estimation in Escherichia coli Central Carbon Metabolism Using Intracellular Free Amino Acids
10.3390/metabo4020408 · 2014 · External reference
Unresolved reference
External reference
10.1021/jacs.7b08486
10.1021/jacs.7b08486 · External reference
Hydrophilic metformin and hydrophobic biguanides inhibit mitochondrial complex I by distinct mechanisms
10.1038/s41594-025-01710-6 · 2026 · External reference
10.1128/aem.72.5.3653-3661.2006
10.1128/aem.72.5.3653-3661.2006 · External reference
10.1128/mmbr.68.4.603-616.2004
10.1128/mmbr.68.4.603-616.2004 · External reference
Metformin use and incidence cancer risk: evidence for a selective protective effect against liver cancer
2018 · External reference
10.1371/journal.pone.0043056
10.1371/journal.pone.0043056 · External reference
